SPDR S&P BIOTECH ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
83.58
-1.66 (-1.95%)
At close: Jul 7, 2025, 4:00 PM
83.92
+0.34 (0.41%)
Pre-market: Jul 8, 2025, 7:48 AM EDT
XBI Holdings Information
XBI is an equity ETF with a total of 129 individual holdings. The top holdings are Exelixis stock at 2.67%, Alnylam Pharmaceuticals at 2.67%, Moderna at 2.63%, United Therapeutics at 2.55%, and Regeneron Pharmaceuticals at 2.53%.
Total Holdings
129
Top 10 Percentage
25.29%
Asset Class
Equity
ETF Category
Health
Assets
4.91B
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
As of Jul 3, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | EXEL | Exelixis, Inc. | 2.67% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.67% |
| 3 | MRNA | Moderna, Inc. | 2.63% |
| 4 | UTHR | United Therapeutics Corporation | 2.55% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 2.53% |
| 6 | NBIX | Neurocrine Biosciences, Inc. | 2.49% |
| 7 | GILD | Gilead Sciences, Inc. | 2.45% |
| 8 | AMGN | Amgen Inc. | 2.45% |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | 2.44% |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 2.41% |
| 11 | HALO | Halozyme Therapeutics, Inc. | 2.40% |
| 12 | BIIB | Biogen Inc. | 2.39% |
| 13 | INSM | Insmed Incorporated | 2.39% |
| 14 | INCY | Incyte Corporation | 2.38% |
| 15 | ABBV | AbbVie Inc. | 2.37% |
| 16 | NTRA | Natera, Inc. | 2.33% |
| 17 | EXAS | Exact Sciences Corporation | 2.30% |
| 18 | BBIO | BridgeBio Pharma, Inc. | 2.16% |
| 19 | BPMC | Blueprint Medicines Corporation | 1.94% |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.83% |
| 21 | TGTX | TG Therapeutics, Inc. | 1.72% |
| 22 | ROIV | Roivant Sciences Ltd. | 1.62% |
| 23 | IONS | Ionis Pharmaceuticals, Inc. | 1.55% |
| 24 | CRSP | CRISPR Therapeutics AG | 1.49% |
| 25 | CYTK | Cytokinetics, Incorporated | 1.47% |
As of Jul 3, 2025